Proof of Usefulness Report

Bactolife

Analysis completed on 2/4/2026

+645
Proof of Usefulness Score
Category Standard

Bactolife is a legitimate, high-potential biotech company (Series B, ~€30M raised Jan 2026, ~$80M total funding) developing 'Binding Proteins' for gut health. While the project itself demonstrates exceptional technical innovation and financial traction (backed by Novo Holdings, Gates Foundation), the submission quality is critically poor. The user claims 'most people have used my product' (false; product launch is 2026) and 'everyone' is the audience (vague). The score is buoyed by the verified external reality of the company's capital and technology, but heavily penalized for submission inaccuracies and lack of current user adoption.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+225
Audience Reach Impact+20
Technical Innovation+171
Evidence Of Traction+180
Market Timing Relevance+95
Functional Completeness+2.5
Subtotal+693.5
Usefulness Multiplierx0.93
Final Score+645

Project Details

Project URL

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline